Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HilleVax
Biotech
Mount Sinai spins out vax venture aimed at infectious diseases
Mount Sinai has spun out CastleVax, a new company based on researchers' vaccine platform aimed at defending against current and future viruses.
Max Bayer
Aug 12, 2022 10:45am
Q2 '22 was weakest quarter for biotech IPOs in more than 5 years
Aug 11, 2022 11:15am
Carlyle's Abingworth buy brings $2 billion for life sciences
Apr 12, 2022 10:00am
Takeda spinout HilleVax hits Wall St., a test of choppy waters
Apr 7, 2022 10:48am